Quick Answer
CUMBERLAND PHARMACEUTICALS INC reported Net Income of -$2.84 million for fiscal year 2025.
CUMBERLAND PHARMACEUTICALS INC Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$2.84M | +56.2% |
| 2024 | -$6.48M | -3.2% |
| 2023 | -$6.28M | -12.7% |
| 2022 | -$5.57M | -58.8% |
| 2021 | -$3.51M | -5.0% |
| 2020 | -$3.34M | +5.6% |
| 2019 | -$3.54M | +49.2% |
| 2018 | -$6.96M | +12.7% |
| 2017 | -$7.98M | -744.6% |
| 2016 | -$944.7K | -229.2% |
| 2015 | $731.4K | -69.8% |
| 2014 | $2.42M | +215.2% |
| 2013 | -$2.10M | -136.0% |
| 2012 | $5.84M | +3.3% |
| 2011 | $5.66M | +130.3% |
| 2010 | $2.46M | -20.5% |
| 2009 | $3.09M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.94M | -25.7% | -162.0% |
| June 30, 2025 | -$740.7K | +31.8% | -158.9% |
| March 31, 2025 | $1.26M | +164.6% | +181.4% |
| September 30, 2024 | -$1.54M | -47.2% | -42.2% |
| June 30, 2024 | -$1.09M | -224.5% | +44.2% |
| March 31, 2024 | -$1.95M | -1112.7% | -85.5% |
| September 30, 2023 | -$1.05M | -156.8% | -220.3% |
| June 30, 2023 | $872.2K | +165.3% | +353.8% |
- CUMBERLAND PHARMACEUTICALS INC showed an increase of +56.2% in Net Income compared to the prior fiscal year.
- Over the 2009–2025 period, CUMBERLAND PHARMACEUTICALS INC’s net income has declined by 191.7% (from $3.09 million to -$2.84 million).
- The most recent figure is from CUMBERLAND PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: